Earnings Per Share
|3 Months Ended|
Mar. 31, 2022
|Earnings Per Share [Abstract]|
|EARNINGS PER SHARE||
The following tables compute basic and diluted earnings per share (in thousands, except per share data):
There were an additional aggregate potentially dilutive weighted-average shares of 1,339,000 and 3,265,000 from convertible securities outstanding for the three months ended March 31, 2022 and 2021. These securities were not considered in calculating diluted net income (loss) per share for the three months ended March 31, 2022 and 2021, as their effect would have been anti-dilutive. At March 31, 2022, the Company had outstanding unexercised warrants to purchase 8.9 million shares of its common stock at an exercise price of $9.76 per share. These warrants expired unexercised on April 28, 2022.
The entire disclosure for earnings per share.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef